| Tyyppi : |
Lehti |
| Internet-yhteys : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=4297 |
|
| Tutkimus Joukkueet : |
Bondy - University Hospital Jean Verdier, Department of Pharmacy |
| Tekijät : |
Kabiche D,Balde I.B,Majoul E,Kabiche S,Bourguignon E,Fontan J-E,Cisternino S,Schlatter J. |
| Otsikko : |
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions. |
| Numero : |
Int J Pharm Compound ; 21, 2: 160-163. 2017 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Hydroxyurea
|
 |
 |
 |
 |
6000 mg
® = Inresa |
| OraPlus® / OraSweet® (1:1) |
>> 60 mL |
|
22-25°C |
 |
| 120 |
 |
|
|
|
|
|
6000 mg
® = Inresa |
| OraPlus® / OraSweet SF® (1:1) |
>> 60 mL |
|
22-25°C |
|
| 120 |
|
|
|
|
|
|
6000 mg
® = Inresa |
|
22-25°C |
|
| 120 |
|
|
|
|
|
|
6000 mg
® = Inresa |
|
22-25°C |
|
| 120 |
|
|
|
|
|
|
6000 mg
® = Inresa |
| OraPlus® / OraSweet® (1:1) |
>> 60 mL |
|
4-8°C |
|
| 120 |
|
|
|
|
|
|
6000 mg
® = Inresa |
| OraPlus® / OraSweet SF® (1:1) |
>> 60 mL |
|
4-8°C |
|
| 120 |
|
|
|
|
|
|
6000 mg
® = Inresa |
|
4-8°C |
|
| 120 |
|
|
|
|
|
|
6000 mg
® = Inresa |
|
4-8°C |
|
| 120 |
|
|
|
|
|
